Skip to main content
SpringerLink
Log in

Entzündungshemmende Medikamente: Glukokortikoide

  • Chapter
Pharmakotherapie bronchopulmonaler Erkrankungen

  • 94 Accesses

Zusammenfassung

Glukokortikoide sind die wichtigste Stoffklasse für die Behandlung entzündlicher Atemwegserkrankungen und einiger. Beispiele für ihre überragende Bedeutung sind das Asthma, bestimmte Stadien und Verlaufe der Sarkoi- dose, die eosinophile Pneumonie und die organisierende Pneumonie (BOOP).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. . Carryer HM, Koelsche GA, Prickmann LE, Maytum CK, Lake CF, Williams HL (1950) The effect of cortisone on asthma and hayfever occuring in subjects sensitive to ragweed pollen. J Allergy 21: 282 – 287

    Article  PubMed  CAS  Google Scholar 

  2. . Hansen K (1957) Allergie. Thieme, Stuttgart

    Google Scholar 

  3. . Fanta CH, Rossing TH, McFadden ER Jr (1983) Glucocorticoids in acute asthma: a critical controlled trial. Am J Med 74: 845 – 851

    Article  PubMed  CAS  Google Scholar 

  4. . Gerdtham UG, Herztmann P, Boman G, Jöns- son B (1993) Impact of inhaled corticosteroids on asthma hospitalization in Sweden: a pooled regression analysis. EFI Research Report, Stockholm

    Google Scholar 

  5. . Campell MJ, Cogmann GR, Holgate ST, John-ston SL (1997) Age specific trends in asthma mortality in England and Wales 1983–1995: results of an observational study. BMJ 314: 1439 – 1441

    Google Scholar 

  6. . BousquetJ, KnaniJ, Henry C, Liard R, Richard A, Michel F-B, Neukirch F (1996) Undertreat- ment in a nonselected population of adult patients with asthma. J Allergy Clin Immunol 98: 514 - 521

    Article  Google Scholar 

  7. . Brattsand R, Axelsson BI (1992) New inhaled glucocorticosteroids. In: Barnes PJ (ed) New drugs for asthma 2, chapter 13. London, pp 193 – 208

    Google Scholar 

  8. . Andersson N, Klint S, Randwall G, Wirén JE (1994) Equipotency of BUD and fluticasone propionate in the vasoconstriction assay. Am J Respir Crit Care Med 149 [Suppl] 4: 2, A467

    Google Scholar 

  9. . Borgström L (1993) Methodical studies on lung deposition. Evaluation of inhaler devices and absorption mechanisms. Comprehensive summaries from the Uppsala Faculty of Pharmacy, University of Uppsala, Act Univ Upps, p 105

    Google Scholar 

  10. . Selroos O, Pietinalho A, Löfroos AB, Riska H (1995) Effect of early versus late intervention with inhaled corticosteroids in asthma. Chest 108: 1228 – 1234

    Article  PubMed  CAS  Google Scholar 

  11. . Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE (1991) Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 87: 483 – 489

    Article  PubMed  CAS  Google Scholar 

  12. . Haahtela T, Jarvinen M, Kava T et al (1994) Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331: 700 – 705

    Article  PubMed  CAS  Google Scholar 

  13. . Martinez FD, Wright AL, Taussig LM et al (1995) Asthma and wheezing in the first six years of life. N Engl J Med 332: 133 – 138

    Article  PubMed  CAS  Google Scholar 

  14. . Mosfeldt Laursen E, Kaae Hansen K, Backer V, Bach-Mortensen N, Prahl P, Koch C (1993) Pulmonary function in adolescents with childhood asthma. Allergy 48: 267 – 272

    Article  PubMed  CAS  Google Scholar 

  15. . Agertoft L, Pedersen S (1994) Effects of long- term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88: 373 – 381

    Article  PubMed  CAS  Google Scholar 

  16. . Foucard T (1996) Aggressive treatment of childhood asthma with local steroids. Good or bad? (review). Allergy 51: 367 – 371

    PubMed  CAS  Google Scholar 

  17. Highlights of the expert panel report 2 (1997) Guidelines for the diagnosis and management of asthma. NIH-Publication 97-4051A

    Google Scholar 

  18. . The British guidelines on asthma management (1997) Thorax 52 [Suppl] 1

    Google Scholar 

  19. . Wallack RL et al (1997) The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. J Allergy Clin Immunol 99: 278 – 285

    Article  Google Scholar 

  20. . ToogoodJH, Baskerville JC, Jennings B, Lef- coe NM, Johansson SA (1982) Influence of dosing frequently and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 70: 288 – 298

    Article  Google Scholar 

  21. . Svedmyr N (1995) Adrenergic beta agonists and corticosteroids in obstructive lung disease. Eur Respir Rev 5 (31): 339 – 346

    Google Scholar 

  22. . Kamada AK, Szefler SJ (1997) How should inhaled glucocorticoids be compared? (editorial) J Allergy Clin Immunol 99: 735 – 737

    PubMed  CAS  Google Scholar 

  23. . Wettengel R et al (1994) Empfehlungen der Deutschen Atemwegsliga zum Asthmamana- gement bei Erwachsenen und bei Kindern. Med Klin 89: 57 – 67

    CAS  Google Scholar 

  24. . Van Schayck CP, van Grunsven PM, Dek- huijzen PNR (1996) Do patients with COPD benefit from treatment with inhaled cortico-steroids? (Editorial) Eur Respir J 9: 1969 – 1972

    Google Scholar 

  25. . Chanez P, Vignola AM, O’Shaugnessy T, En- ander I, Li D, Jeffery PK, Bousquet J (1997) Corticosteroid reversiblity in COPD is related to features of asthma. Am J Respir Crit Care Med 155: 1529 – 1534

    PubMed  CAS  Google Scholar 

  26. . Turner-Warwick M, Burrows B, Johnson A (1980) Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 35: 593 – 599

    Article  PubMed  CAS  Google Scholar 

  27. . Johnson MA, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M (1989) Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44: 280 – 288

    Article  PubMed  CAS  Google Scholar 

  28. . Gibson PG, Wong BJ, Hepperle MJ, Kline PA, Girgis-Gabardo A, Guyatt G, Dolovich J, Denburg JA, Ramsdale EH, Hargreave FE (1992) A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 22: 525 – 532

    Article  PubMed  CAS  Google Scholar 

  29. . Clark DJ, Lipworth BJ (1997) Dose-response of inhaled drugs in asthma: an update. Clin Pharmacokinet 32 (1): 58 – 74

    Article  PubMed  CAS  Google Scholar 

  30. . Pedersen S, Ramsgaard-Hansen O (1995) Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 95: 29 – 33

    Article  PubMed  CAS  Google Scholar 

  31. . Albert RK, Martin TR, Lewis SW (1980) Con-trolled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 92: 753 – 758

    PubMed  CAS  Google Scholar 

  32. . Murate GH, Gorby MS, Chick TW, Halperin AK (1990) Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD: effect on patients with a history of multiple relapses. Chest 98: 845 - 849

    Article  Google Scholar 

  33. . Callahan CM, Dittus RS, Katz BP (1991) Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease (review). Ann Inter Med 114: 216 – 223

    CAS  Google Scholar 

  34. . Dompeling E, van Schayck CP, Molema J, Folgering H, van Grunsven PM, van Weel C (1992) Inhaled beclomethason improves the course of asthma and COPD. Eur Respir J 34: 945 – 952

    Google Scholar 

  35. . Kerstjens HAM, Brand PLP, Hughes MD et al (1992) A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 327: 1413 – 1419

    Article  PubMed  CAS  Google Scholar 

  36. . Renkema TEJ, Schouten JP, Koeter GH, Postma DS (1996) Effects of long-term treatment with corticosteroids in COPD. Chest 109: 1156 – 1162

    Article  PubMed  CAS  Google Scholar 

  37. . Derenne JPh (1995) Effects on high-dose in-haled beclomethasone on the rate of decline in FEV1 in patients with chronic obstructive pulmonary disease: results of a 2 years prospective multicentre study (abstract). Am J Respir Crit Care Med 151, A463

    Google Scholar 

  38. . Pedersen S, O’Byrne P (1997) A comparison of the efficancy and safety of inhaled corticosteroids in asthma. Allergy 52 [Suppl] 39: 1 – 34

    Google Scholar 

  39. . Webb J, Clark TJH (1981) Recovery of plasma corticotropin and Cortisol levels after a three- week course of prednisolon. Thorax 36: 22 – 24

    Article  PubMed  CAS  Google Scholar 

  40. . Streck WG, Lockwood DH (1976) Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 66: 910 – 914

    Article  Google Scholar 

  41. . McEvoy CE, Niewoehner DE (1997) Adverse effects of corticosteroid therapy for COPD: a critical review. Chest 111: 732 – 743

    Article  PubMed  CAS  Google Scholar 

  42. . Adcock IM, Stevens DA, Barnes PJ (1996) Interactions of glucocorticoids and (32-agonists. Eur Respir J 9: 160 – 168

    Article  PubMed  CAS  Google Scholar 

  43. . Rea HH, Garret JE, Lanes SF, Birmann BM, Kobe J (1996) The association between asthma drugs and severe life-threatening attacks. Chest 110: 1446 – 1451

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Wettengel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Wilhelminenspital der Stadt Wien, Wien, Österreich

    Friedrich Kummer

  2. Ruhrlandklinik, Essen, Deutschland

    Nikolaus Konietzko

  3. Universitätsspital, Zürich, Schweiz

    Tullio C. Medici

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag/Wien

About this chapter

Cite this chapter

Wettengel, R. (2000). Entzündungshemmende Medikamente: Glukokortikoide. In: Kummer, F., Konietzko, N., Medici, T.C. (eds) Pharmakotherapie bronchopulmonaler Erkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6761-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6761-8_6

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7404-3

  • Online ISBN: 978-3-7091-6761-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation